Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_assertion type Assertion NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_head.
- NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_assertion description "[Here, we demonstrate that, similarly to what previously observed by us in human prostate and breast tumor samples, hypoxia increases expression of the receptor for advanced glycation end products (RAGE) and the purinergic receptor P2X7 (P2X7R).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_provenance.
- NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_assertion evidence source_evidence_literature NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_provenance.
- NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_assertion SIO_000772 21642357 NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_provenance.
- NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_assertion wasDerivedFrom befree-20140225 NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_provenance.
- NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_assertion wasGeneratedBy ECO_0000203 NP916768.RAA9aR_g_0Nbb6SXSFRIuY_4RVHYnc0kt-NYGnizd3H-c130_provenance.